Lets just hope the FDA and BP don't concoct a way for the IP to be stolen from pphm.
Lets hope they don't block the road until pphm has to cry uncle and then BP steals it for a pittance cutting management a sweet deal. I personally do not trust any of them.
Greatest Post Ever! Post this on every national newspaper, TV, media, Peregrine Pharm........With upcoming Data info, this is how you sell!!! and become acknowledged... Get the WORD OUT to everyone and everyone will back you...
Tremendous Job on points, BIOPHARM!!! Always appreciated..JM
biopharm: whoahhh! I think the platform is moving forward in approximate relationship to its worth, but I've said for some long time that if Bavi- is as good as we think it is, who on earth needs a partner? We still don't know how good it is, similar to a game of 5 card stud with scrambled top cards and an unknown in the hole. We'll see. Meanwhile PPHM is providing some seminal research for the public and big pharma for a most nominal price tag.
i agree you post is truly a piece of great work. would you consider that maybe a lot of this has been already agreed withe the FDA and BIG PHARMA and that is why we are seeing this doling out of shares with the aid of the ATM. we all have to agree that somebody is accumulating pphm yet it hasn't moved more then the 10 cents spread. i would like to suggest that each of big pharma is being allotted a certain amount of shares at said price and so as to be fair to all.
Is it feasible that "IF" all Big Pharma and the FDA knows that PS is the target and "EVERY" cancer drug will benefit as seen in solid tumors blah blah blah
One big hole in this theory is the FDA most likely denied BTD and or AA so it's safe to say they don't think PS is all that great of a target. At least not one that needs to be expedited.
The fact that bavi does not have a BTD means the FDA does not think its a breakthrough therapy. If the FDA thought bavi was a breakthrough therapy bavi would have been granted a breakthrough therapy designation status. comprendi? not rocket science.